Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development

Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development

Hsa-miRNA-326 (miR-326) has recently been discovered having anticancer efficacy in different organs. However, the role of miR-326 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-326 on the development of NSCLC. The results indicated that miR-3...

Full description

Bibliographic Details
Main Authors: Sun, Chengcao, Huang, Chuanfeng, Li, Shujun, Yang, Cuili, Xi, Yongyong, Wang, Liang, Zhang, Feng, Fu, Yunfeng, Li, Dejia
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884997/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884997/

Similar Items